Xencor Inc 4

Barbara Klencke received 10,302 RSU shares of Xencor Inc. common stock and a stock option grant for 20,604 shares at $12.20 per share as equity compensation.

On June 16, 2026, Barbara Klencke received an equity compensation package from Xencor Inc. consisting of 10,302 shares of common stock in the form of restricted stock units and a stock option grant for 20,604 shares of common stock at an exercise price of $12.20 per share, with no cash consideration paid at grant. Following these awards, she directly beneficially owned 29,974 shares of common stock, and she also held the option covering 20,604 shares that will vest in equal monthly installments over one year from June 16, 2026 to June 16, 2027, while the RSUs will fully vest on the first anniversary of the grant date. Based on the $12.20 option exercise price as a proxy for current value, her post‑transaction common stock holdings are worth approximately $365,683, and the option award represents an additional potential value of about $251,369, underscoring a meaningful, but routine, alignment of her incentives with shareholders through equity compensation.

Filing Facts

CIK

1326732

Ticker

XNCR

Form

4

Source Type

fda

Accession

0001647647-26-000002

Alert Tier

5